MindMaze Therapeutics
MindMaze Therapeutics
MindMaze Therapeutics develops precision neurotherapeutic combinations that integrate behavior, software, medical devices and data to treat neurological disease and improve brain health. The company’s mission is to accelerate recovery and long‑term management for patients with conditions such as stroke, Parkinson’s, Alzheimer’s and traumatic brain injury by delivering scalable, clinically validated digital treatments and measurement tools.
What we build
We offer a portfolio of commercially available solutions and supporting technology designed for clinics and home use, including:
- MindPod – an immersive, game‑based platform to support motor and cognitive recovery.
- MindMotion GO – a behavioral neurorehabilitation system for clinical and home settings.
- Izar – a smart peripheral for hand motor rehabilitation.
- Physilog – a digital motion assessment platform providing 3D motion analytics and digital biomarkers.
Impact & locations
MindMaze Therapeutics deploys solutions through clinical partners and trials worldwide and collects large-scale patient data to improve outcomes. The company is headquartered in Lausanne, Switzerland, and provides global support to clinics and research partners.